Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heart mapping could make AFib ablation more effective

NCT ID NCT07630857

First seen Jun 05, 2026 · Last updated Jun 23, 2026 · Updated 4 times

Summary

This study tests a new way to guide catheter ablation for atrial fibrillation (AF), a common heart rhythm problem. The technique uses unipolar voltage mapping to find specific electrical signals (QS potentials) that may help keep AF going. Researchers will compare this personalized approach to standard ablation in 200 people with AF, checking if it reduces recurrence after 3 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fuwai Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100037, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

catheter ablation guided by unipolar QS-potential mapping

What this could lead to

If successful, this could lead to a more personalized and effective ablation procedure for atrial fibrillation, potentially reducing the chance of the heart rhythm problem coming back.

What could go wrong

This is an early-stage study with only 200 participants, so results may not apply to everyone. The new mapping technique may not be better than the standard approach, and there are typical risks of catheter ablation like bleeding or heart damage.

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.